SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Infectious Disease

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2161932

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2161932

Cold and Flu Supplements Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 7295
Printable PDF & Excel (Enterprise License above 5 users)
USD 8495

Add to Cart

Description

Table of Contents

Introduction

The Cold and Flu Supplements Market encompasses vitamins, minerals, herbal extracts, probiotics and combination formulas that consumers use to support immune health, reduce the risk of seasonal infections and ease symptoms when they occur. These products have become a routine part of household wellness, particularly during the winter months when respiratory illnesses peak. In 2026, the market is valued at US$24.65 Bn and is projected to reach US$54.6 Bn by 2033, registering a CAGR of 12.00%. Strong growth reflects rising health awareness, demanding respiratory seasons and a preference for self-care solutions that complement conventional medicines.

Consumer behaviour is evolving from occasional purchases of single-ingredient products toward year-round use of multi-ingredient formulas designed for prevention as well as relief. Shoppers are increasingly informed, comparing ingredients, dosage formats and scientific support before buying. At the same time, digital retail and direct-to-consumer brands are making it easier to discover new products, encouraging trial and expanding the reach of specialised immune support offerings.

Market Insights

The market is segmented by product type, form, application, consumer demographics and distribution channel. Product types include vitamins and minerals, herbal and botanical supplements, probiotics and synbiotics, combination formulations and other supplements. Herbal and botanical supplements are among the fastest-growing categories, expanding at a 13.8% CAGR as consumers seek natural ingredients. Forms include tablets and capsules, gummies, powders, syrups and liquids, and lozenges and others, with powders growing at 13.6% because they mix easily into drinks and allow flexible dosing.

Applications cover cold prevention, flu prevention, symptom relief, immune-system support and respiratory health. Consumer groups include adults, children and seniors, and the senior segment is growing at 13.4% as older consumers prioritise immune resilience. Distribution spans pharmacies and drugstores, supermarkets and hypermarkets, specialty health stores, e-commerce and direct-to-consumer channels, with e-commerce growing fastest at 14.6%. A broader trend is the move from single-ingredient vitamin C products toward multi-ingredient formulas that combine vitamins, minerals, botanicals and probiotics.

Drivers

Severe respiratory seasons are a major driver, carrying high impact in North America and Europe. Years with intense cold, flu and other respiratory virus activity heighten public concern about infection and recovery time, prompting consumers to stock up on immune support products and symptom relief supplements. Repeated exposure to such seasons has also reinforced preventive habits that persist beyond peak periods.

Growing doubts about over-the-counter decongestants are a second driver, with medium impact in North America. A November 2024 US regulatory proposal to remove oral phenylephrine from the over-the-counter monograph raised questions about the effectiveness of some common cold remedies, encouraging consumers to explore supplement-based alternatives. Restraints influence the pace of growth. Mixed scientific evidence and claim rules have medium impact over the long term, limiting what brands can say about benefits. Seasonal demand swings and product recalls, including a June 2025 nasal swab recall, carry medium short-term impact, creating volatility in sales and inventory planning for manufacturers and retailers.

Business Opportunity

Traditional-medicine brands are opening an Asia Pacific revenue pool. Consumers across the region have long relied on herbal and traditional remedies for colds and respiratory health, and modern brands that package these ingredients in convenient, quality-assured formats are finding strong demand. Combining heritage formulations with contemporary manufacturing standards, clear labelling and digital marketing allows companies to reach younger, urban consumers while retaining the trust associated with traditional practices.

Science-led premium formulas create a higher-margin segment. As shoppers become more discerning, many are willing to pay more for products backed by clinical research, standardised extracts and transparent dosing. Brands that invest in studies, clearly communicate evidence and design multi-ingredient formulas around specific needs, such as prevention, symptom relief or respiratory support, can differentiate themselves from low-cost alternatives. This positioning also helps companies navigate claim regulations more confidently. Together, regional traditional medicine and evidence-based premium products offer complementary growth paths that support both volume expansion and stronger profitability across the forecast period.

Region Analysis

North America leads the market with a 35.2% share in 2026, supported by high supplement usage, strong retail pharmacy networks and consumer interest in alternatives to conventional decongestants. Severe respiratory seasons in recent years have further strengthened preventive purchasing habits across the region.

Asia Pacific is the fastest-growing region, expanding at a 14.1% CAGR. Rising disposable incomes, expanding e-commerce access and deep cultural familiarity with herbal and traditional remedies are driving rapid uptake of cold and flu supplements, particularly in urban markets. Europe represents a significant market where severe respiratory seasons and established herbal medicine traditions support demand, although its specific regional share is not stated. Latin America is an emerging market with growing pharmacy retail and increasing health awareness, and its share is not specified. The Middle East and Africa are developing gradually as access to modern retail and online channels improves, while their regional share is likewise not stated in the available data for the forecast period.

Key Players

  • Haleon
  • Church & Dwight
  • Nestle Health Science
  • Pharmavite
  • Schwabe Group
  • Boiron
  • PharmaCare (Sambucol)
  • Nature's Way
  • Blackmores
  • Himalaya Wellness

Segmentation

By Product Type:

  • Vitamins & Minerals
  • Herbal & Botanical Supplements
  • Probiotics & Synbiotics
  • Combination Formulations
  • Other Supplements

By Form:

  • Tablets & Capsules
  • Gummies
  • Powders
  • Syrups & Liquids
  • Lozenges & Others

By Application:

  • Cold Prevention
  • Flu Prevention
  • Symptom Relief
  • Immune-System Support
  • Respiratory Health

By Consumer Demographics:

  • Adults
  • Children
  • Seniors

By Distribution Channel:

  • Pharmacies & Drugstores
  • Supermarkets & Hypermarkets
  • Specialty Health Stores
  • E-commerce
  • Direct-to-Consumer

By Geographic Coverage:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Cold and Flu Supplements Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Cold and Flu Supplements Market Outlook, 2020-2033

  • 3.1. Global Cold and Flu Supplements Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 3.1.1. Vitamins & Minerals
    • 3.1.2. Herbal & Botanical Supplements
    • 3.1.3. Probiotics & Synbiotics
    • 3.1.4. Combination Formulations
    • 3.1.5. Other Supplements
  • 3.2. Global Cold and Flu Supplements Market Outlook, by Form, Value (US$ Bn), 2020-2033
    • 3.2.1. Tablets & Capsules
    • 3.2.2. Gummies
    • 3.2.3. Powders
    • 3.2.4. Syrups & Liquids
    • 3.2.5. Lozenges & Others
  • 3.3. Global Cold and Flu Supplements Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 3.3.1. Cold Prevention
    • 3.3.2. Flu Prevention
    • 3.3.3. Symptom Relief
    • 3.3.4. Immune-System Support
    • 3.3.5. Respiratory Health
  • 3.4. Global Cold and Flu Supplements Market Outlook, by Consumer Demographics, Value (US$ Bn), 2020-2033
    • 3.4.1. Adults
    • 3.4.2. Children
    • 3.4.3. Seniors
  • 3.5. Global Cold and Flu Supplements Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
    • 3.5.1. Pharmacies & Drugstores
    • 3.5.2. Supermarkets & Hypermarkets
    • 3.5.3. Specialty Health Stores
    • 3.5.4. E-commerce
    • 3.5.5. Direct-to-Consumer
  • 3.6. Global Cold and Flu Supplements Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.6.1. North America
    • 3.6.2. Europe
    • 3.6.3. Asia Pacific
    • 3.6.4. Latin America
    • 3.6.5. Middle East & Africa

4. North America Cold and Flu Supplements Market Outlook, 2020-2033

  • 4.1. North America Cold and Flu Supplements Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 4.1.1. Vitamins & Minerals
    • 4.1.2. Herbal & Botanical Supplements
    • 4.1.3. Probiotics & Synbiotics
    • 4.1.4. Combination Formulations
    • 4.1.5. Other Supplements
  • 4.2. North America Cold and Flu Supplements Market Outlook, by Form, Value (US$ Bn), 2020-2033
    • 4.2.1. Tablets & Capsules
    • 4.2.2. Gummies
    • 4.2.3. Powders
    • 4.2.4. Syrups & Liquids
    • 4.2.5. Lozenges & Others
  • 4.3. North America Cold and Flu Supplements Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 4.3.1. Cold Prevention
    • 4.3.2. Flu Prevention
    • 4.3.3. Symptom Relief
    • 4.3.4. Immune-System Support
    • 4.3.5. Respiratory Health
  • 4.4. North America Cold and Flu Supplements Market Outlook, by Consumer Demographics, Value (US$ Bn), 2020-2033
    • 4.4.1. Adults
    • 4.4.2. Children
    • 4.4.3. Seniors
  • 4.5. North America Cold and Flu Supplements Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
    • 4.5.1. Pharmacies & Drugstores
    • 4.5.2. Supermarkets & Hypermarkets
    • 4.5.3. Specialty Health Stores
    • 4.5.4. E-commerce
    • 4.5.5. Direct-to-Consumer
  • 4.6. North America Cold and Flu Supplements Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.6.1. U.S. Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 4.6.2. U.S. Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 4.6.3. U.S. Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 4.6.4. U.S. Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 4.6.5. U.S. Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 4.6.6. Canada Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 4.6.7. Canada Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 4.6.8. Canada Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 4.6.9. Canada Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 4.6.10. Canada Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
  • 4.7. BPS Analysis/Market Attractiveness Analysis

5. Europe Cold and Flu Supplements Market Outlook, 2020-2033

  • 5.1. Europe Cold and Flu Supplements Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 5.1.1. Vitamins & Minerals
    • 5.1.2. Herbal & Botanical Supplements
    • 5.1.3. Probiotics & Synbiotics
    • 5.1.4. Combination Formulations
    • 5.1.5. Other Supplements
  • 5.2. Europe Cold and Flu Supplements Market Outlook, by Form, Value (US$ Bn), 2020-2033
    • 5.2.1. Tablets & Capsules
    • 5.2.2. Gummies
    • 5.2.3. Powders
    • 5.2.4. Syrups & Liquids
    • 5.2.5. Lozenges & Others
  • 5.3. Europe Cold and Flu Supplements Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 5.3.1. Cold Prevention
    • 5.3.2. Flu Prevention
    • 5.3.3. Symptom Relief
    • 5.3.4. Immune-System Support
    • 5.3.5. Respiratory Health
  • 5.4. Europe Cold and Flu Supplements Market Outlook, by Consumer Demographics, Value (US$ Bn), 2020-2033
    • 5.4.1. Adults
    • 5.4.2. Children
    • 5.4.3. Seniors
  • 5.5. Europe Cold and Flu Supplements Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
    • 5.5.1. Pharmacies & Drugstores
    • 5.5.2. Supermarkets & Hypermarkets
    • 5.5.3. Specialty Health Stores
    • 5.5.4. E-commerce
    • 5.5.5. Direct-to-Consumer
  • 5.6. Europe Cold and Flu Supplements Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.6.1. Germany Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 5.6.2. Germany Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 5.6.3. Germany Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 5.6.4. Germany Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 5.6.5. Germany Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 5.6.6. Italy Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 5.6.7. Italy Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 5.6.8. Italy Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 5.6.9. Italy Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 5.6.10. Italy Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 5.6.11. France Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 5.6.12. France Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 5.6.13. France Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 5.6.14. France Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 5.6.15. France Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 5.6.16. U.K. Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 5.6.17. U.K. Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 5.6.18. U.K. Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 5.6.19. U.K. Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 5.6.20. U.K. Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 5.6.21. Spain Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 5.6.22. Spain Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 5.6.23. Spain Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 5.6.24. Spain Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 5.6.25. Spain Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 5.6.26. Russia Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 5.6.27. Russia Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 5.6.28. Russia Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 5.6.29. Russia Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 5.6.30. Russia Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 5.6.31. Rest of Europe Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 5.6.32. Rest of Europe Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 5.6.33. Rest of Europe Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 5.6.34. Rest of Europe Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 5.6.35. Rest of Europe Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
  • 5.7. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Cold and Flu Supplements Market Outlook, 2020-2033

  • 6.1. Asia Pacific Cold and Flu Supplements Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 6.1.1. Vitamins & Minerals
    • 6.1.2. Herbal & Botanical Supplements
    • 6.1.3. Probiotics & Synbiotics
    • 6.1.4. Combination Formulations
    • 6.1.5. Other Supplements
  • 6.2. Asia Pacific Cold and Flu Supplements Market Outlook, by Form, Value (US$ Bn), 2020-2033
    • 6.2.1. Tablets & Capsules
    • 6.2.2. Gummies
    • 6.2.3. Powders
    • 6.2.4. Syrups & Liquids
    • 6.2.5. Lozenges & Others
  • 6.3. Asia Pacific Cold and Flu Supplements Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 6.3.1. Cold Prevention
    • 6.3.2. Flu Prevention
    • 6.3.3. Symptom Relief
    • 6.3.4. Immune-System Support
    • 6.3.5. Respiratory Health
  • 6.4. Asia Pacific Cold and Flu Supplements Market Outlook, by Consumer Demographics, Value (US$ Bn), 2020-2033
    • 6.4.1. Adults
    • 6.4.2. Children
    • 6.4.3. Seniors
  • 6.5. Asia Pacific Cold and Flu Supplements Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
    • 6.5.1. Pharmacies & Drugstores
    • 6.5.2. Supermarkets & Hypermarkets
    • 6.5.3. Specialty Health Stores
    • 6.5.4. E-commerce
    • 6.5.5. Direct-to-Consumer
  • 6.6. Asia Pacific Cold and Flu Supplements Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.6.1. China Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 6.6.2. China Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 6.6.3. China Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 6.6.4. China Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 6.6.5. China Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 6.6.6. Japan Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 6.6.7. Japan Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 6.6.8. Japan Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 6.6.9. Japan Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 6.6.10. Japan Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 6.6.11. South Korea Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 6.6.12. South Korea Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 6.6.13. South Korea Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 6.6.14. South Korea Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 6.6.15. South Korea Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 6.6.16. India Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 6.6.17. India Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 6.6.18. India Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 6.6.19. India Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 6.6.20. India Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 6.6.21. Southeast Asia Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 6.6.22. Southeast Asia Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 6.6.23. Southeast Asia Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 6.6.24. Southeast Asia Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 6.6.25. Southeast Asia Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 6.6.26. Rest of SAO Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 6.6.27. Rest of SAO Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 6.6.28. Rest of SAO Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 6.6.29. Rest of SAO Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 6.6.30. Rest of SAO Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
  • 6.7. BPS Analysis/Market Attractiveness Analysis

7. Latin America Cold and Flu Supplements Market Outlook, 2020-2033

  • 7.1. Latin America Cold and Flu Supplements Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 7.1.1. Vitamins & Minerals
    • 7.1.2. Herbal & Botanical Supplements
    • 7.1.3. Probiotics & Synbiotics
    • 7.1.4. Combination Formulations
    • 7.1.5. Other Supplements
  • 7.2. Latin America Cold and Flu Supplements Market Outlook, by Form, Value (US$ Bn), 2020-2033
    • 7.2.1. Tablets & Capsules
    • 7.2.2. Gummies
    • 7.2.3. Powders
    • 7.2.4. Syrups & Liquids
    • 7.2.5. Lozenges & Others
  • 7.3. Latin America Cold and Flu Supplements Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 7.3.1. Cold Prevention
    • 7.3.2. Flu Prevention
    • 7.3.3. Symptom Relief
    • 7.3.4. Immune-System Support
    • 7.3.5. Respiratory Health
  • 7.4. Latin America Cold and Flu Supplements Market Outlook, by Consumer Demographics, Value (US$ Bn), 2020-2033
    • 7.4.1. Adults
    • 7.4.2. Children
    • 7.4.3. Seniors
  • 7.5. Latin America Cold and Flu Supplements Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
    • 7.5.1. Pharmacies & Drugstores
    • 7.5.2. Supermarkets & Hypermarkets
    • 7.5.3. Specialty Health Stores
    • 7.5.4. E-commerce
    • 7.5.5. Direct-to-Consumer
  • 7.6. Latin America Cold and Flu Supplements Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.6.1. Brazil Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 7.6.2. Brazil Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 7.6.3. Brazil Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 7.6.4. Brazil Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 7.6.5. Brazil Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 7.6.6. Mexico Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 7.6.7. Mexico Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 7.6.8. Mexico Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 7.6.9. Mexico Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 7.6.10. Mexico Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 7.6.11. Argentina Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 7.6.12. Argentina Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 7.6.13. Argentina Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 7.6.14. Argentina Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 7.6.15. Argentina Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 7.6.16. Rest of LATAM Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 7.6.17. Rest of LATAM Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 7.6.18. Rest of LATAM Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 7.6.19. Rest of LATAM Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 7.6.20. Rest of LATAM Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
  • 7.7. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Cold and Flu Supplements Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Cold and Flu Supplements Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 8.1.1. Vitamins & Minerals
    • 8.1.2. Herbal & Botanical Supplements
    • 8.1.3. Probiotics & Synbiotics
    • 8.1.4. Combination Formulations
    • 8.1.5. Other Supplements
  • 8.2. Middle East & Africa Cold and Flu Supplements Market Outlook, by Form, Value (US$ Bn), 2020-2033
    • 8.2.1. Tablets & Capsules
    • 8.2.2. Gummies
    • 8.2.3. Powders
    • 8.2.4. Syrups & Liquids
    • 8.2.5. Lozenges & Others
  • 8.3. Middle East & Africa Cold and Flu Supplements Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 8.3.1. Cold Prevention
    • 8.3.2. Flu Prevention
    • 8.3.3. Symptom Relief
    • 8.3.4. Immune-System Support
    • 8.3.5. Respiratory Health
  • 8.4. Middle East & Africa Cold and Flu Supplements Market Outlook, by Consumer Demographics, Value (US$ Bn), 2020-2033
    • 8.4.1. Adults
    • 8.4.2. Children
    • 8.4.3. Seniors
  • 8.5. Middle East & Africa Cold and Flu Supplements Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
    • 8.5.1. Pharmacies & Drugstores
    • 8.5.2. Supermarkets & Hypermarkets
    • 8.5.3. Specialty Health Stores
    • 8.5.4. E-commerce
    • 8.5.5. Direct-to-Consumer
  • 8.6. Middle East & Africa Cold and Flu Supplements Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.6.1. GCC Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 8.6.2. GCC Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 8.6.3. GCC Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 8.6.4. GCC Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 8.6.5. GCC Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 8.6.6. South Africa Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 8.6.7. South Africa Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 8.6.8. South Africa Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 8.6.9. South Africa Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 8.6.10. South Africa Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 8.6.11. Egypt Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 8.6.12. Egypt Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 8.6.13. Egypt Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 8.6.14. Egypt Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 8.6.15. Egypt Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 8.6.16. Nigeria Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 8.6.17. Nigeria Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 8.6.18. Nigeria Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 8.6.19. Nigeria Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 8.6.20. Nigeria Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
    • 8.6.21. Rest of Middle East Cold and Flu Supplements Market Outlook, by Product Type, 2020-2033
    • 8.6.22. Rest of Middle East Cold and Flu Supplements Market Outlook, by Form, 2020-2033
    • 8.6.23. Rest of Middle East Cold and Flu Supplements Market Outlook, by Application, 2020-2033
    • 8.6.24. Rest of Middle East Cold and Flu Supplements Market Outlook, by Consumer Demographics, 2020-2033
    • 8.6.25. Rest of Middle East Cold and Flu Supplements Market Outlook, by Distribution Channel, 2020-2033
  • 8.7. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Haleon
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Church & Dwight
    • 9.4.3. Nestle Health Science
    • 9.4.4. Pharmavite
    • 9.4.5. Schwabe Group
    • 9.4.6. Boiron
    • 9.4.7. PharmaCare (Sambucol)
    • 9.4.8. Nature's Way
    • 9.4.9. Blackmores
    • 9.4.10. Himalaya Wellness

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!